Clinical Trials


Clinical trials are research studies used to find out whether new treatments are safe and effective, and work better than current treatments. Clinical trials are strictly monitored and carefully evaluated.






A multi-center Phase 3 open-label, randomized study.
A man with his arms crossed, smiling

The SPLASH Study is for men with prostate cancer that has spread beyond the prostate and progressed after hormone therapy. Your doctor will determine whether the SPLASH study may be right for you.

Learn More at the official trial website or NCT04647526 at

Phase 1

FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER).

Learn more about NCT05432193 at

Prospective single arm, multicenter study

Sponsored by the University Health Network (Toronto, Ontario, Canada), a prospective single arm, multicenter study to evaluate the efficacy and safety of Lutetium-177 Octreotate in patients with neuroendocrine tumors who has positive Somatostatin receptor identified by 68Ga-DOTATATE

Learn more about NCT027437411 at